Page 49 - Abt News Today

By Dean Seal The chief executive of Assertio Holdings is stepping down and will be succeeded for the time being by an independent director. The specialty...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target upped by equities research analysts at Raymond James from $110.00 to $124.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the healthcare product maker’s stock. Raymond James’ target price would suggest a potential […]

Arcblock (ABT) traded up 3.1% against the dollar during the 24 hour period ending at 11:00 AM E.T. on January 3rd. During the last seven days, Arcblock has traded 0.4% higher against the dollar. Arcblock has a total market capitalization of $20.93 million and approximately $1.98 million worth of Arcblock was traded on exchanges in […]

Prentiss Smith & Co. Inc. increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 41,801 shares of the healthcare product maker’s stock after buying an additional 607 shares during the period. Abbott Laboratories accounts for about 3.0% of Prentiss Smith & […]

Prentiss Smith & Co. Inc. raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,801 shares of the healthcare product maker’s stock after purchasing an additional 607 shares during the […]

Sippican Capital Advisors decreased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,065 shares of the healthcare product maker’s stock after selling 495 shares during the quarter. Sippican Capital Advisors’ holdings […]

Mead Johnson Nutrition voluntarily recalled more than 675,000 cans of Nutramigen Hypoallergenic Infant Formula Powder.

Clear Creek Financial Management LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,038 shares of the healthcare product maker’s stock after buying an additional 363 shares […]

1834 Investment Advisors Co. reduced its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,707 shares of the healthcare product maker’s stock after selling 588 shares during the quarter. […]

Stratos Wealth Partners LTD. grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 133,103 shares of the healthcare product maker’s stock after buying an additional 5,630 shares during the period. Stratos Wealth […]